Discover and read the best of Twitter Threads about #NafdacRelease
Most recents (2)
NAFDAC Vaccine Committee Review of AstraZeneca/Oxford #COVID19 (COVISHIELD) Vaccine (Serum Institute of India)
RECOMMENDATION FOR EMERGENCY USE AUTHORISATION
#NafdacRelease
Full press release ➡️ bit.ly/3k7bSPp
RECOMMENDATION FOR EMERGENCY USE AUTHORISATION
#NafdacRelease
Full press release ➡️ bit.ly/3k7bSPp
The use of AstraZeneca/Oxford #COVID19Vaccine was given an approval for Emergency Use Listing (EUL) by WHO on Monday, February 15, 2021. WHO’s EUL assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX Facility vaccine supply.
It also allows countries to expedite their own regulatory approval to import and administer #COVID19 vaccines. The EUL will allow Nigeria to receive the first batch of the vaccine from COVAX Facility within weeks subject to approval by NAFDAC.
NAFDAC’s Position on Local Claims for #COVID19 Remedies
#NafdacRelease
Read more here ⬇️⬇️
nafdac.gov.ng/nafdacs-positi…
#NafdacRelease
Read more here ⬇️⬇️
nafdac.gov.ng/nafdacs-positi…
NAFDAC as at the time of this press release has only received application from one company for a product the company is presenting (for approval) for the treatment of the symptoms, and not for the cure of #COVID19 as a disease.
A claim of cure must be subjected to clinical evaluation through well controlled, randomized clinical trials following an approved clinical trial protocol.
